Esbriet 801 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FA2P4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,449
Award facts
- Contract value 100% obligated
- $10,449.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., received a firm fixed-price delivery order valued at $10,449.43 from the Defense Logistics Agency (DLA) on January 15, 2026, for 90 tablets of Esbriet 801 mg. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of February 6, 2026. This competitively awarded, non-set-aside contract represents a small-value transaction under Amerisourcebergen's broader relationship with DLA, which leverages the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026.
Esbriet (pirfenidone) is a specialty pharmaceutical used in the treatment of idiopathic pulmonary fibrosis, reflecting DLA's need to procure specialized medications for military healthcare systems. Amerisourcebergen's extensive federal contract portfolio demonstrates its established capability to supply critical pharmaceutical products efficiently across multiple therapeutic domains. The contract underscores the Defense Logistics Agency's reliance on major pharmaceutical distributors to support military treatment facilities and veteran healthcare programs with essential medications required to sustain readiness and personnel health across the federal medical system.
Quick answers
Who was awarded contract SPE2DR26FA2P4?
SPE2DR26FA2P4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FA2P4 worth?
The government has obligated $10,449 on SPE2DR26FA2P4.
Is contract SPE2DR26FA2P4 an order under another contract?
Yes. SPE2DR26FA2P4 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA2P4 competed?
The extent of competition for SPE2DR26FA2P4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award